WNT signalling: mechanisms and therapeutic opportunities

Gunnar Schulte; Vitezslav Bryja

doi:10.1111/bph.14065

WNT signalling: mechanisms and therapeutic opportunities

Br J Pharmacol. 2017 Dec;174(24):4543-4546. doi: 10.1111/bph.14065.

Authors

Gunnar Schulte^{1

2}, Vitezslav Bryja²

Affiliations

¹ Section for Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
² Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.

Abstract

This themed section of the British Journal of Pharmacology stems from the EMBO Conference: Wnt Meeting 2016 held from the 14^th to 16^th September 2016 in Brno, Czech Republic.

Linked articles: This article is part of a themed section on WNT Signalling: Mechanisms and Therapeutic Opportunities. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.24/issuetoc.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / pharmacology*
Cell Membrane / drug effects*
Cell Membrane / metabolism
Humans
Neoplasms / drug therapy*
Neoplasms / metabolism
Neoplasms / pathology
Wnt Signaling Pathway / drug effects*

Substances

Antineoplastic Agents